NA Proactive news snapshot: Gatling Exploration, BioLargo, Silver Range, Predictmedix, AIM ImmunoTech UPDATE …

Gatling Exploration Inc (CVE:GTR)(OTCQX:GATGF) has commenced a 13,000 meter drill program at its Larder Gold project in Ontario’s Abitibi greenstone belt. Drilling will initially focus on connecting the Fernland and Cheminis deposits in order to establish a continuous 4.5 kilometer (km) mineralized trend. Upcoming phases will test the western extension of Fernland, as well as near surface mineralization at all three high-grade deposits. Regional mapping and sampling at priority target areas is also now underway. The Larder property hosts three high-grade gold deposits along the Cadillac-Larder Lake Break, 35 kms east of Kirkland Lake. The project is 100% controlled by Gatling. The 3,370 hectare project area is positioned 7 kms west of the Kerr Addison Mine, which produced 11 million ounces of gold.

BioLargo Inc (OTCQB:BLGO) announced Monday increasing demand for its Clyraguard Personal Protection Spray, a disinfectant designed to decontaminate medical devices such as face masks and other personal protection equipment (PPE). “The product has been met with great enthusiasm, and sales are ramping up,” the company said in a statement. As part of a multi-phase product roll-out plan, subsidiary Clyra Medical Technologies has secured a $1 million inventory line of credit and formed relationships with three contract-manufacturers that are actively producing the spray.

Silver Range Resources Ltd (CVE:SNG) revealed it is set to option its drill-ready Cold Springs project in Nevada to Volt Energy Corp (CVE:VOLT). Cold Springs is a low sulphidation epithermal prospect around 80 km east of the city Fallon on Highway 50 in Churchill County, said prospect generator Silver Range.Volt can acquire a 75% stake by paying Silver Range a total of C$300,000 in cash and performing a minimum of 2,000 meters of drilling over a three-year period. Silver Range will retain a 2.5% net smelter return (NSR) that can be bought down to 1% for a cash payment of C$1.25million. The pair have agreed to complete a definitive agreement before the end of August this year.

Predictmedix Inc (CSE:PMED) (OTCQB:PMEDF) has announced two major new deployments of its coronavirus (COVID-19) symptom screening technology. The Toronto-based firm is rolling out the technology at the Flow Water facility in Ontario and at a 24-hour pharmacy in Montreal, it said. Predictmedix has proprietary artificial intelligence technology to screen for infectious diseases such as influenza and coronaviruses, recently developing a predictive mass screening tool for COVID-19. The technology is used to predict and identify individuals who have the highest likelihood of being infected with the virus.

AIM ImmunoTech Inc (NYSEAMERICAN:AIM) revealed growing cash on hand and updated investors on the advancement of its drug Ampligen as a treatment for the coronavirus (COVID-19) in a business and clinical update released Monday. The company had cash, cash equivalents and marketable securities of $40.3 million as of June 30, nearly 5 times more than the $8.8 million it had at the end of 2019. On the coronavirus front, Ampligen’s Phase 1/2a trial of ampligen with Roswell Park Comprehensive Cancer Center is on track to commence patient enrollment soon, the company said. The trial will examine Ampligen in combination with interferon alfa-2b in cancer patients with COVID-19. 

Loop Insights Inc (CVE:MTRX) will present its contact tracing solutions to one of the largest associations of US college sports, it said Monday. The Canadian artificial intelligence company will make a presentation to athletic directors of 11 NCAA Division 1 colleges in the Big East Conference, which represents more than 150,000 students attending schools like Georgetown and Villanova universities. The conference is looking for a solution to help the division restart sporting activities in a safe and secure way after it postponed its fall sports season amid the coronavirus pandemic.

NetCents Technology Inc. (CSE:NC) (FSE: 6N) (OTCQB:NTTCF) has entered into a partnership with XTM, Inc. (CSE:PAID) (FSE:7XT), a Toronto-based Fintech company in the challenger banking space, providing mobile banking and payment solutions around the world, to enable cryptocurrency payments and loading of payment cards. Through the partnership, NetCents will be supplying the underlying technology to power cryptocurrency transactions for XTM’s card programs enabling near real-time loading of funds to XTM mobile wallets. Cryptocurrency account holders can redeem the amount needed to complete an online or card transaction. The partnership marks the second NetCents collaboration that leverages the Company’s deep technology base. The first collaboration on technology has been NetCents work with VISA as part of their Fast Track technology incubator.

Steppe Gold Ltd (TSE:STGO), the Mongolia-focused precious metals producer, said it was seeing good cashflow from its flagship ATO mine in the country as it posted first-quarter results, which showed strong output from the asset. The miner said production for the three months to June 30 came in at 15,389 ounces of gold and 4,978 ounces of silver. The firm sold 12,458 gold ounces and 3,728 silver ounces in the period with average realized prices per ounce of US$1,714 and US$15 respectively, making the firm C$19.5 million in sales. “With cash costs under US$600 in this ramp-up phase, and over 1m tonnes of ore now mined and paid for, we are seeing the strong cash flow generation of this first phase of the ATO project,” Steppe’s CEO Bataa Tumur-Ochir said in a statement.

Phunware Inc (NASDAQ:PHUN) announced Monday it clocked up $2.2 million in second-quarter revenue as it looks to accelerate revenues for the remainder of 2020. The company, which offers a fully integrated enterprise cloud platform for mobile that provides products, solutions, data and services for brands worldwide, said $2 million in revenue came from platform subscriptions and services. Gross margin was 65.3%. However, Phunware said the ongoing coronavirus (COVID-19) pandemic affected sales in the quarter ended June 30, 2020. 

Lord Global Corporation (OTCMKTS:LRDG) said its 100%-owned subsidiary, 27Health Inc., which has exclusive marketing rights to CoviGuard, which it believes to be the first and only oral sanitizer spray and mouthwash on the market. has received an order for one million units of the 4oz spray from Global Sanitizers Technologies Inc. The company’s Oral Sanitizer product noted this is designed to be the first product on the market to significantly reduce the viral and bacterial loads in the oral and mucosa membrane (mouth and throat). Global Sanitizer Technologies has one of the largest vertically integrated supply chains of hand sanitizers, gels and sanitizer surface sprays in the US.

KULR Technology Group Inc (OTCQB:KULR) cut its losses by almost half in the second quarter of its current year, alongside a triple-digit jump in revenues. For the three months ended June 30, 2020, the company reported an operating loss of US$323,141, a 48% improvement on the same period a year ago, while revenues surged by 257% to US$201,128 driven by what the group said was a two-fold increase in customer transactions. KULR said it had sales transactions with ten customers in the second quarter of 2020, more than double the number a year ago, which it said reflected management’s commitment to building new customer relationships through a growing pool of referrals and business development leads.

Nemaura Medical Inc (NASDAQ:NMRD) announced Monday it has about $18 million in cash to help fund the development and commercialization of its diabetes diagnostic devices and subscription services.   The company said it ended its first quarter on June 30, 2020, with $5.9 million in cash but raised an additional $10.7 million a month later via a fundraising scheme.  Nemaura also noted that it further strengthened its financial position heading into its current second quarter by reducing research and development as well as general and administrative expenses in April, May and June. During its first-quarter it also narrowed its comprehensive loss to $1.095 million compared to a loss of $1.267 million in the year-ago quarter.

NexTech AR Solutions Corp (CSE:NTAR) (OTCQB:NEXCF) said it has begun a major expansion of its augmented reality (AR) ecommerce business over the past two months, inking deals with some with major brands. Over the past 60 days, NexTech noted that it has signed distribution deals with Dyson, Philips Norelco, MR. Coffee, VitaMix, MetroVac, Breville and Cuisinart. The agreements allow the company to leverage its full AR technology stack, which includes its WebAR, ARitize360 app and 3D/AR advertising network. “Up until 60 days [ago], Miele [Vacuums} accounted for the majority of our AR ecommerce business,” NexTech CEO Evan Gappelberg said in a statement. “Now with seven major new brands and more in the works, we are exponentially increasing our AR e-commerce revenue potential.”

Milestone Scientific Inc (NYSEAMERICAN:MLSS) told investors that its sales and business development pipeline was expanding, despite the challenges posed by the coronavirus (COVID-19) pandemic, as it reported its second-quarter results. The group's main focus remains the commercialization of its CompuFlo Epidural System, which it believes will become the new standard of care, and the firm highlighted that it is now in late-stage discussions with a number of premier hospitals in the US. Milestone's revenues in the three months to June 30. 2020, were hit, however, due to reduced hours and closings of dental offices throughout the US and the rest of the world due to the pandemic, affecting the firm's wand product, which makes injections less painful.

Helix Technologies Inc (OTCQB:HLIX) said it has achieved all of its financial goals for 2020 already, “setting the stage for an outstanding and exciting rest of the year” as the group reported a revenue surge in its first half. For the first six months of its current year, Helix reported revenues of US$9,3 million, an increase of 28% over the same period last year, while its adjusted earnings (EBITDA) expanded to US$2 million from US$259,000. For its second quarter, the company said its cash flows from operations rose 162% year-on-year to US$446,000, adding that the number of clients using its Cannalytics platform more than doubled in the quarter to over 200.

CytoDyn Inc (OYCQB:CYDY) has provided the topline report from its recent Phase 2 trial of leronlimab in mild-to-moderate coronavirus patients to the US Food and Drug Administration and requested emergency use approval, the company announced Monday.  The company has also sent the report to regulatory authorities in Mexico, the UK, the Philippines and the European Union. The trial utilized the National Early Warning Score (NEWS), a scale developed by the Royal College of Physicians to identify patients at risk for rapid clinical deterioration requiring critical care. NEWS2, the latest version, measures clinical parameters including respiratory rate, oxygen saturation, supplemental oxygen, temperature, systolic blood pressure, heart rate, and level of consciousness.

Talon Metals Corp (TSE:TLO), the nickel-focused junior, told investors it spent C$1.3 million on its Tamarack nickel-copper-cobalt project in the three months to end-June, 2020.  The group is focused on producing nickel for the rapidly growing electric vehicles (EV) industry and is in a joint venture with mining titan Rio Tinto (LON:RIO) on the high-grade asset, which lies in Minnesota, USA, and consists of the Tamarack North project and the Tamarack South project. Talon can earn up to 60% of the project. In a statement, the firm said its capitalized exploration costs and deferred expenditures on the project in the second quarter amounted to C$1.3 million versus C$1.5million for the same period in 2019. The total capitalized exploration cost at the project to June 30 this year came in at C$59.7 million, it added.

PreveCeutical Medical Inc (CSE:PREV) (OTCWB:PRVCF) (FSE:18H) said it has received around A$1.23 million (US$833,966) in a cash rebate from the Australian Federal Government’s Research and Development (R&D) Incentive Program. The company said the rebate related to expenditure across its portfolio on eligible Australian R&D activities during the financial year ended December 31, 2019, including the Sol-gel nose-to-brain drug delivery system and the non-addictive analgesics programs, conducted at the University of Queensland. PreveCeutical added that the funding will support and reinforce its continued investments in its R&D programs.

TRACON Pharmaceuticals Inc (NASDAQ:TCON) revealed Monday that the US Food and Drug Administration (FDA) has given the go-ahead for its human trial of envafolimab for sarcoma cancer and the firm said it expects to start enrolling patients in the trial at 25 sites in the US in the fourth quarter of 2020. The group noted that the FDA granted approval to start the pivotal ENVASARC study after it filed the protocol as part of an Investigational New Drug (IND) application on July 15 this year. "Immunotherapy has radically changed the treatment paradigm for a number of cancers and our hope is envafolimab will do the same for sarcoma patients who have few treatment options," Dr James Freddo, chief medical officer of TRACON said in a statement.

LexaGene Holdings Inc (CVE:LXG) (OTCQB:LXXGF) announced Monday another milestone in its journey to commercially launch flagship analyzer product MiQLab before the end of September - the hiring of LaunchWorks as its contract manufacturer. LaunchWorks is an FDA registered, ISO 13485 certified, cGMP compliant group specializing in manufacturing consumables for life science firms, LexaGene said. It will manufacture the assay panels and buffer sets used in LexaGene’s fully automated MiQLab system.

TIMIA Capital Corporation (CVE:TCA) (OTCMKTS:TIMCF) has successfully exited from its investment in Wagepoint, an online payroll software firm. The investment of C$2 million generated a gain of around C$500,000 under TIMIA’s non-dilutive financing model, according to the Vancouver-based firm. Since the initial financing in December 2017, Wagepoint has paid TIMIA $2.7 million in a combination of return of principal, interest and early redemption payments. The company called the $500,000 gain an example of the periodic gains that TIMIA's fintech platform has produced, which has a “meaningful impact” on its earnings per share. The buyout of the Wagepoint financing will be included in the firm’s 3Q consolidated results.

Esports Entertainment Group Inc (NASDAQ:GMBL) said it has expanded its partnership with Dignitas, the esports vertical of New Meta Entertainment Inc (NME), as part of which it has also secured the naming rights of Dignitas’ famed Counter Strike: Global Offensive (CS:GO) team. The company said that in addition to the integration of its online betting platform, VIE.gg, into the CS:GO naming rights and jersey, the partners will also roll out strategic digital and physical activations with the New Jersey marketplace as a core focus. The firm added that the partnership also paves the way for entry into the European market through association with the Dignitas CS:GO team, who hail from Scandinavia.

O3 Mining Inc (CVE:OIII) told investors that drilling has started on its Malartic property in Quebec to expand existing zones along strike and at depth and to explore regional targets. The firm said the work would focus on the Orion 8 zone, which previously produced 22,252 ounces (oz) of gold at 5.82 grams per ton (g/t) and the Gold Hawk, Malartic H, North Shear and North-North zones and around 30,000 metres out of the ongoing 150,000 metre (m) drilling program has been allocated to the Malartic property. "The Marban project is a very important asset in our multimillion-ounce portfolio," O3 Mining president and CEO Jose Vizquerra said In a statement.

Agile Therapeutics Inc (NASDAQ:AGRX), which is preparing to commercialize its Twirla patch contraceptive, has appointed Dr Paul Korner as its chief medical officer. Dr Korner is a board-certified obstetrician and gynecologist with more than 20 years of pharmaceutical and biotech industry experience, including significant experience within women’s healthcare. He will be responsible for supporting the commercial launch of Twirla, advancing the company’s internal pipeline and evaluating external growth opportunities. He will report to CEO Al Altomari. 

Pure Gold Mining Inc. (CVE:PGM) (LON:PUR) has reported that the forest fire which had been active in the area south of the town of Red Lake is now under control and the evacuation order for the municipality of Red Lake has been rescinded. The company said power and access has been restored to site and it is transitioning to a full resumption of mine activities. Both surface and underground inspections have been completed and the group has confirmed that there is no damage to infrastructure or equipment at the mine site. The temporary shutdown had no material impact on the site’s development schedule with first gold pour expected in the four quarter of 2020, it added.

Zimtu Capital Corp. has signed an agreement with Ximen Mining Corp. to provide its ZimtuAdvantage program. Zimtu shall receive $6,250 per month for a period of twelve months, with the entire 12 months payable at the beginning of the contract. ZimtuADVANTAGE is a program designed to provide opportunities, guidance, cost savings and assistance to clients covering multiple aspects of being a public company. The services may include building financial networks, building business networks, shared costs with other public companies, building a social media presence, conference opportunities, media outlets and guidance and special group pricing provided by Zimtu's network of public company professionals. The program provides the flexibility to allow companies to customize the products and services to best support their needs.

MGX Minerals Inc (CSE:XMG) (OTCMKTS:MGXMF) has issued the results of a petrographical study (mineral content of rock) on a high-grade sample from the Heino Money gold deposit in British Columbia, which it says will guide upcoming metallurgy and process design work, expected to begin by the end of August this year. Summarizing the report from the Vancouver Petrographic Lab, MGX said: "In this sample (#303), native gold occurs grossly with sulphides, but in detail, it is mainly concentrated in silicates (quartz and Mineral A), and is concentrated strongly in one patch 1.5-2 mm across. This detailed distribution would be important if and when the time comes for any metallurgical extraction of gold." Sample 303 weighed 0.94kg and showed 207 parts per million (ppm) gold and 94ppm silver, 1.015% lead and 3.38% zinc. Heino-Money was active between 1981 and 1993 and produced around 5,800 tons of gold and silver ore.

GR Silver Mining Ltd (CVE:GRSL) said the TSX Venture Exchange has accepted for filing the company's proposal to issue 427,375 shares at a deemed price of 47.5 cents to settle outstanding debt for $203,003 with 12 creditors.

Mineworx Technologies Ltd (CVE:MWX) said the TSX Venture Exchange has accepted for filing documentation with respect to a non-brokered private placement announced June 9, 2020, which see the issue of 120 debentures at $1,000 each convertible into common shares at 10 cents per share with a maturity date of 24 months from the date of issuance and an interest rate of 12% per annum, together with the issue of 1.2 million warrants exercisable at 12 cents for a period of 24 months from the date of issuance with three placees.

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, has announced that Positive Physicians Holdings, Inc. (OTCQX:PPHI), a Pennsylvania domiciled holding company, has qualified to trade from today on the OTCQX Best Market, having previously traded on NASDAQ. Trading on the OTCQX Market offers companies efficient, cost-effective access to the U.S. capital markets. Streamlined market requirements for OTCQX are designed to help companies lower the cost and complexity of being publicly traded, while providing transparent trading for their investors. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance, and demonstrate compliance with applicable securities laws. Dr Lewis S. Sharps, PPHI's President and CEO, commented: "We anticipate that this transition should have a positive impact on share value by reducing the company's reporting expenses while having a minimal impact on our shareholders."

Algernon Pharmaceuticals Inc. (CSE:AGN) (OTCQB:AGNPF) has announced that its CEO, Christopher J. Moreau, will be providing an update on the group's two clinical trial programs on a BioPub webcast Wednesday August 19, 2020 hosted by Dr KSS at 12.00pm EDT. Interested shareholders, investors, members of the media and the public can listen to the interview free of charge via the webinar ID: 874 4612 5520: https://us02web.zoom.us/j/87446125520; o or iPhone one-tap: US: +16465588656, 87446125520#  or +16699009128, 87446125520#; or dial  US: +1 646 558 8656  or +1 669 900 9128  or +1 253 215 8782  or +1 301 715 8592  or +1 312 626 6799  or +1 346 248 7799. International numbers available: https://us02web.zoom.us/u/kdOyMvvDkk. BioPub, a  biotech investment discussion website, has been analyzing small-cap special situation biotech investments for seven years to readers in over 40 countries.

Jay Taylor, in the July 16, 2020, edition of Gold, Energy & Tech Stocks, has repeated his buy Benchmark Metals Inc. (CVE:BNCH), recently 65 cents. He previously said buy on July 16, 2019, at 31.5 cents and on January 14, 2020, at 41 cents. Assuming a $1,000 investment for each of the two buys, the $2,000 position is now worth $3,648. Benchmark has started a 50,000-metre drill program on its Lawyers gold-silver project in north-central British Columbia. The project has an existing open-pit resource of 1.92 million ounces, and Benchmark is aiming to boost that figure to five million. It should have a new resource estimate in late 2020 or early 2021, followed by a preliminary economic assessment. Such work should "move this story onto the radar screens of major institutions," Taylor said. He encourages readers to invest sooner than that or "a major portion of the upside may be gone."

Jay Taylor, in the July 16, 2020, edition of Gold, Energy & Tech Stocks, has refreshed his buy on Great Bear Resources Ltd. (CVE:GBR), recently $16.82. Taylor said buy five times from February 15, 2018, to April 17, 2020, at prices ranging from 53 cents to $7.83. Assuming a $1,000 investment for each of the five buys, the $5,000 position is now worth a pleasing $49,787. "Oh my goodness! More unbelievably great news!" is how Taylor kicks off his update on Great Bear. The company's Dixie gold project in Ontario continues to be "like an amazing dream." Great Bear previously made progress outlining two zones called Dixie Limb and Hinge, and now a step-out program has found what appears to be a Hinge look-alike, called Arrow. "[This] supports the strong ongoing discovery potential,” declared Great Bear’s management. He expects the economics to be “exceptionally strong” and potentially lead to a “very competitive bidding process” among major miners and said Great Bear remains a great buy.

Osprey Gold Development Ltd. (CVE:NSAU) has obtained an interim order from the Supreme Court of British Columbia for its proposed plan of arrangement, previously announced on March 23, 2020, and June 10, 2020, under which Megumagold Corp. (CNSX:NSAU) will acquire all of Osprey’s outstanding common shares in exchange for common shares of Megumagold, on an exchange ratio of one Megumagold common share for every two Osprey common shares outstanding. Osprey has also mailed related materials for the special general meeting of shareholders of Osprey to be held on September 4, 2020, at 10.00am Vancouver time to consider and vote on the approval of the transaction. In light of the ongoing coronavirus (COVID-19) pandemic, the meeting will be held by way of virtual-only format and all registered shareholders and duly appointed proxyholders can attend the meeting online at https://web.lumiagm.com/293413588, using password OS2020.

Blackrock Gold Corp. (CVE:BRC) (OTCMKTS:BKRRF) has filed a technical report titled, “Technical Report on the Silver Cloud Property, Elko County, Nevada, USA,” with an effective date of July 29, 2020. The technical report was independently completed for the company by Nancy J. Wolverson, CPG, consulting geologist, of Reno, Nevada, in accordance with National Instrument 43-101 (Standards of Disclosure for Mineral Projects). The technical report is available under Blackrock’s SEDAR profile or on the company’s website.

Story by ProactiveInvestors